Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects With Active Crohn's Disease.

NCT02367183 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02367183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02367183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects With Active Crohn's Disease.
Lead sponsor
Celgene
Phase
Phase 1
Overall status
Completed
Start date
April 8, 2015
Completion date
December 14, 2017
Enrollment
64 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease